Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bioxyne Limited ( (AU:BXN) ) has provided an announcement.
Bioxyne Limited has applied for quotation on the ASX of 14,480,556 new fully paid ordinary shares, to be listed under its ticker BXN. The shares have been issued under an employee incentive scheme and are scheduled to be quoted from 30 January 2026, modestly increasing the company’s quoted capital base and reflecting ongoing use of equity-based remuneration for staff and executives.
The most recent analyst rating on (AU:BXN) stock is a Buy with a A$0.04 price target. To see the full list of analyst forecasts on Bioxyne Limited stock, see the AU:BXN Stock Forecast page.
More about Bioxyne Limited
Average Trading Volume: 1,615,228
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$86.79M
Learn more about BXN stock on TipRanks’ Stock Analysis page.